<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is an important public health problem worldwide, being the fourth most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in men and the third most common in women </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> incidence is higher in developing countries due to the prevalence of <z:hpo ids='HP_0001513'>obesity</z:hpo> associated with reduced physical activity </plain></SENT>
<SENT sid="2" pm="."><plain>Rectal mucinous <z:mp ids='MP_0002038'>carcinomas</z:mp>, especially the "signet ring cell" type, have a worse prognosis compared with other varieties of colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp>, being diagnosed in more advanced stage and more prone to lymph node and <z:e sem="disease" ids="C0346989" disease_type="Neoplastic Process" abbrv="">peritoneal metastases</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Our study comprised 37 cases with <z:mp ids='MP_0009315'>rectal adenocarcinoma</z:mp> with mucinous component operated in the Surgical Clinics of the Emergency County Hospital of Craiova, between 2006 and 2010 </plain></SENT>
<SENT sid="4" pm="."><plain>The aim of this study was to evaluate some molecular prognostic factors for rectal mucinous <z:mp ids='MP_0002038'>carcinomas</z:mp> namely B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> 2 (Bcl-2) and epidermal growth factor receptor (EGFR), and their correlations with the main morpho-clinical parameters of these patients </plain></SENT>
<SENT sid="5" pm="."><plain>Thus, we immunohistochemically assessed the degree of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells in mucinous rectal <z:mp ids='MP_0002038'>carcinomas</z:mp> using the Bcl-2 marker, and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:hpo ids='HP_0000718'>aggressiveness</z:hpo> using the EGFR responsiveness </plain></SENT>
<SENT sid="6" pm="."><plain>In our study, the percentage of Bcl-2+ cases was 43.24%, with no significant statistical correlation between the Bcl-2 expression and histopathological subtype of mucinous <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>The evaluation of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:hpo ids='HP_0000718'>aggressiveness</z:hpo> in terms of EGFR responsiveness showed a reduced expression in <z:mp ids='MP_0002038'>carcinomas</z:mp> correlated with the increase in quantity of the mucinous component </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, EGFR reactivity was increased in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion front </plain></SENT>
</text></document>